JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sdringola, S.
Right arrow Articles by Gould, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sdringola, S.
Right arrow Articles by Gould, K. L.
Journal of Nuclear Medicine Vol. 47 No. 1 59-67
© 2006 by Society of Nuclear Medicine


Clinical Investigation

Mechanisms of Progression and Regression of Coronary Artery Disease by PET Related to Treatment Intensity and Clinical Events at Long-Term Follow-up

Stefano Sdringola, MD1–3,, Catalin Loghin, MD2,3, Fernando Boccalandro, MD2,3 and K. Lance Gould, MD1,3

1 The Weatherhead PET Center For Preventing and Reversing Atherosclerosis, University of Texas Medical School at Houston, Houston, Texas; 2 Division of Cardiology, Department of Medicine, University of Texas Medical School at Houston, Houston, Texas; and 3 Memorial Hermann Hospital, Houston, Texas

Correspondence: For correspondence or reprints contact: K. Lance Gould, MD, The Weatherhead PET Center, University of Texas Medical School at Houston, 6431 Fannin St., Room 4.256 MSB, Houston, TX 77030. E-mail: gould{at}pet.med.uth.tmc.edu

Changes in regional myocardial perfusion throughout the entire coronary vascular tree, as opposed to changes in the worst regional perfusion defect, have not been described during long-term regression or progression of coronary artery disease (CAD) or related to clinical outcomes. Methods: Four-hundred nine patients with CAD undergoing dipyridamole PET at baseline and after 2.6 ± 1.4 y were followed over 5 more years for coronary events. PET images were objectively quantified by automated software for changes in severity of the (i) baseline worst quadrant, indicating the worst flow-limiting stenosis at baseline PET; (ii) follow-up worst quadrant, indicating the worst stenosis on follow-up PET; and (iii) maximal change quadrant, indicating the largest change of any same quadrant pair from baseline–to–follow-up images. Results: At follow-up PET, new regional perfusion defects were seen in 40% of patients. In 77% of patients, the greatest change was in a quadrant different from the worst baseline defect. The maximal change quadrant improved in 70% of patients on intense lifestyle and pharmacologic lipid treatment, in 48% on moderate treatment, and in 39% on poor treatment (P < 0.0001). Combined quadrant changes integrated throughout the heart independently predicted cardiovascular events at long-term follow-up. In contrast, changes of any single baseline–to–follow-up quadrant pair did not. Conclusion: By PET, 77% of patients with CAD had the greatest perfusion changes in areas different from the baseline worst perfusion defect and 40% had new perfusion defects. Changes in perfusion defects throughout the entire coronary vascular tree predicted coronary events, whereas changes in the worst flow-limiting stenosis at baseline or in any one segment of myocardium did not. To our knowledge, these data provide the first direct evidence on mechanisms for disproportionately greater reduction in cardiac events than changes in single stenosis severity with lipid treatment.

Key Words: coronary artery disease • PET • risk factors • myocardial perfusion • progression–regression CAD




This article has been cited by other articles:


Home page
JNMHome page
K. L. Gould, T. Pan, C. Loghin, N. P. Johnson, and S. Sdringola
Reducing Radiation Dose in Rest-Stress Cardiac PET/CT by Single Poststress Cine CT for Attenuation Correction: Quantitative Validation
J. Nucl. Med., May 1, 2008; 49(5): 738 - 745.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. L. Gould
Not All Randomized Trials Are Equal
J. Am. Coll. Cardiol., November 13, 2007; 50(20): 2013 - 2015.
[Full Text] [PDF]


Home page
JNMHome page
K. L. Gould, T. Pan, C. Loghin, N. P. Johnson, A. Guha, and S. Sdringola
Frequent Diagnostic Errors in Cardiac PET/CT Due to Misregistration of CT Attenuation and Emission PET Images: A Definitive Analysis of Causes, Consequences, and Corrections
J. Nucl. Med., July 1, 2007; 48(7): 1112 - 1121.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. S. Hochman and P. G. Steg
Does Preventive PCI Work?
N. Engl. J. Med., April 12, 2007; 356(15): 1572 - 1574.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2006 by the Society of Nuclear Medicine.